Xubo Wu

812 total citations
30 papers, 554 citations indexed

About

Xubo Wu is a scholar working on Molecular Biology, Surgery and Cancer Research. According to data from OpenAlex, Xubo Wu has authored 30 papers receiving a total of 554 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 9 papers in Surgery and 8 papers in Cancer Research. Recurrent topics in Xubo Wu's work include RNA modifications and cancer (7 papers), Cancer-related molecular mechanisms research (6 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Xubo Wu is often cited by papers focused on RNA modifications and cancer (7 papers), Cancer-related molecular mechanisms research (6 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Xubo Wu collaborates with scholars based in China and United States. Xubo Wu's co-authors include Ran Tao, Qimeng Chang, Jianfa Wang, Zhiqiu Hu, Jin-Feng Feng, Chenghong Peng, Ziping Zhang, Ziping Zhang, Baosan Han and Fei Teng and has published in prestigious journals such as SHILAP Revista de lepidopterología, Analytical Chemistry and Journal of Controlled Release.

In The Last Decade

Xubo Wu

28 papers receiving 547 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xubo Wu China 13 284 178 153 125 77 30 554
Jinglin Wang China 12 206 0.7× 101 0.6× 103 0.7× 37 0.3× 43 0.6× 25 533
Guangli Ren China 12 214 0.8× 90 0.5× 65 0.4× 139 1.1× 30 0.4× 20 543
Krista L. Denning United States 13 211 0.7× 111 0.6× 108 0.7× 230 1.8× 56 0.7× 50 585
Lingjian Zhang China 14 199 0.7× 76 0.4× 85 0.6× 51 0.4× 38 0.5× 37 565
Hanwei Li China 14 209 0.7× 129 0.7× 133 0.9× 39 0.3× 27 0.4× 27 604
Shaohua Li China 13 177 0.6× 91 0.5× 97 0.6× 45 0.4× 38 0.5× 34 476
Yingying Tan China 12 316 1.1× 92 0.5× 60 0.4× 99 0.8× 58 0.8× 32 607
Xuewen Zhang China 12 240 0.8× 116 0.7× 59 0.4× 63 0.5× 35 0.5× 34 523

Countries citing papers authored by Xubo Wu

Since Specialization
Citations

This map shows the geographic impact of Xubo Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xubo Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xubo Wu more than expected).

Fields of papers citing papers by Xubo Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xubo Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xubo Wu. The network helps show where Xubo Wu may publish in the future.

Co-authorship network of co-authors of Xubo Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Xubo Wu. A scholar is included among the top collaborators of Xubo Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xubo Wu. Xubo Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Qinghe, et al.. (2025). Black phosphorus nanosheets fortified with catalase to enhance Schwann cell responses for neural repair. Journal of Controlled Release. 380. 579–598. 2 indexed citations
2.
3.
Wu, Qinghe, et al.. (2024). Ultrathin BSA‐Stabilized Black Phosphorous Nanoreactor Boosts Mild‐Temperature Photothermal Therapy Through Modulation of Cellular Self‐Defense Fate. Advanced Healthcare Materials. 13(31). e2402079–e2402079. 7 indexed citations
4.
Wu, Xubo, et al.. (2024). Regenerating Chemotherapeutics through Copper‐Based Nanomedicine: Disrupting Protein Homeostasis for Enhanced Tumor Therapy. Advanced Healthcare Materials. 13(28). e2401954–e2401954. 6 indexed citations
5.
Chang, Qimeng, Xiang Zhou, Jin-Feng Feng, et al.. (2024). <i>ALKBH5</i> promotes hepatocellular carcinoma cell proliferation, migration and invasion by regulating <i>TTI1</i> expression. SHILAP Revista de lepidopterología. 24(5). 1216–1230. 2 indexed citations
6.
Liu, Zhigang, Chen Lin, Zhuo Wang, et al.. (2024). Liquid Biopsy-Based Accurate Diagnosis and Genomic Profiling of Hard-to-Biopsy Tumors via Parallel Single-Cell Genomic Sequencing of Exfoliated Tumor Cells. Analytical Chemistry. 96(36). 14669–14678. 2 indexed citations
7.
Xu, Yayun, Jianfa Wang, Xubo Wu, et al.. (2023). Gut microbiota alteration after cholecystectomy contributes to post-cholecystectomy diarrhea via bile acids stimulating colonic serotonin. Gut Microbes. 15(1). 2168101–2168101. 26 indexed citations
8.
9.
Yang, Qing, Xubo Wu, Ruifang Guan, et al.. (2022). Integration of pharmacodynamics, network pharmacology and metabolomics to elucidate effect and mechanism of Artemisia capillaris Thunb. in the treatment of jaundice. Journal of Ethnopharmacology. 303. 115943–115943. 9 indexed citations
10.
Xu, Yayun, Hui Jing, Jianfa Wang, et al.. (2022). Disordered Gut Microbiota Correlates With Altered Fecal Bile Acid Metabolism and Post-cholecystectomy Diarrhea. Frontiers in Microbiology. 13. 800604–800604. 31 indexed citations
11.
Chang, Qimeng, Yayun Xu, Jianfa Wang, et al.. (2022). Effect of aging on acute pancreatitis through gut microbiota. Frontiers in Microbiology. 13. 897992–897992. 8 indexed citations
12.
Chang, Qimeng, Yayun Xu, Jianfa Wang, et al.. (2021). SLC41A3 Exhibits as a Carcinoma Biomarker and Promoter in Liver Hepatocellular Carcinoma. Computational and Mathematical Methods in Medicine. 2021. 1–9. 5 indexed citations
13.
Wang, Jianfa, et al.. (2021). RORγt inhibitor SR1001 alleviates acute pancreatitis by suppressing pancreatic IL‐17‐producing Th17 and γδ‐T cells in mice with ceruletide‐induced pancreatitis. Basic & Clinical Pharmacology & Toxicology. 129(5). 357–368. 6 indexed citations
14.
Zhang, Juxiang, Qimeng Chang, Xubo Wu, et al.. (2020). Correction to: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research. 39(1). 8 indexed citations
15.
Teng, Fei, Juxiang Zhang, Qimeng Chang, et al.. (2020). LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research. 39(1). 235–235. 97 indexed citations
16.
Hu, Zhiqiu, Ziping Zhang, Fei Teng, et al.. (2020). Role of Asxl2 in non‑alcoholic steatohepatitis‑related hepatocellular carcinoma developed from diabetes. International Journal of Molecular Medicine. 47(1). 101–112. 7 indexed citations
17.
Liu, Jiazhe, Hongcheng Wang, Jianfa Wang, et al.. (2019). Total flavonoid aglycones extract in Radix Scutellariae induces cross-regulation between autophagy and apoptosis in pancreatic cancer cells. Journal of Ethnopharmacology. 235. 133–140. 30 indexed citations
18.
Yang, Mengxuan, Yingying Qu, Xubo Wu, et al.. (2016). Ubiquitin-conjugating enzyme UbcH10 promotes gastric cancer growth and is a potential biomarker for gastric cancer. Oncology Reports. 36(2). 779–786. 21 indexed citations
19.
Wu, Xubo & Ran Tao. (2012). Hepatocyte differentiation of mesenchymal stem cells. Hepatobiliary & pancreatic diseases international. 11(4). 360–371. 78 indexed citations
20.
Wu, Xubo, Chenghong Peng, Fang Huang, et al.. (2011). Preparation and characterization of chitosan porous microcarriers for hepatocyte culture. Hepatobiliary & pancreatic diseases international. 10(5). 509–515. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jinglin Wang Breakdown of academic impact, for papers by Guangli Ren Breakdown of academic impact, for papers by Krista L. Denning Breakdown of academic impact, for papers by Lingjian Zhang Breakdown of academic impact, for papers by Hanwei Li Breakdown of academic impact, for papers by Shaohua Li Breakdown of academic impact, for papers by Yingying Tan Breakdown of academic impact, for papers by Xuewen Zhang
Rankless by CCL
2026